Adams claims BBC NI broadcast was an “attempted hatchet job”

The two American financial giants paid €322m for the discounted mortgage book offloaded by Rabobank almost three years ago. They are still bouncing some borrowers around in search of higher profit.

Has Ireland found a new source of gold, or is the country still finding a new way to help multinationals to minimise their tax bills?

A year ago, Flipdish achieved unicorn status. Since then, it has shed jobs, and new accounts reveal that it is in the midst of a restructure that management believes will leave it on a much better financial footing.

Eoin Goulding built Integrity360 into Ireland’s biggest cybersecurity company, before selling a majority stake to August Equity. He now hopes to acquire Altada out of receivership.

Saudi Arabia are determined to lessen their dependence on oil by 2030 but their pursuit of the biggest names in sport is more likely to become a vanity project rather than a fulfilling policy.

One of the immediate advantages of EEC membership that continues to this day is that Ireland and its citizens became part of something bigger.

Reits everywhere have been clobbered by rising interest rates. In Ireland, they are unsure of their welcome. What's their role in our system, and what's coming this year?

Russian sanctions saw a Norwegian cruise company in a "chicken and egg" legal scenario as it scrabbled to refinance Russian loans secured on its vessels and secure a protective court order. The first legal battle was in London. Now, it's Dublin's turn.

They say their insurance policies were meant to pay out in 90 days for aeroplanes lost by acts of war. Yet nearly a year after Russia's full-scale invasion of Ukraine, some of the world's largest aircraft lessors are fighting tooth and nail for compensation.

The latest layoffs at Salesforce show the correction in the tech industry is not over, raising questions about Ireland's corporation tax boom. Another tax stream, however, gives an indication of the profits yet to be declared here – and that's before we even look at big pharma.